MEDIQON Group AG Announces Bond Buyback Offer

MEDIQON Group AG has initiated an offer to repurchase up to EUR 9 million nominal amount of the 2020 bond. This announcement comes after the company made a commitment in May 2023 to launch one or more public buyback offers contingent upon specific conditions being met. The decision to proceed with this first offer, which represents 36% of the issued bond volume, was made possible by receiving funds from the repayment of shareholder loans issued in previous years.

The Management Board, with approval from the Supervisory Board, has decided on this move to strengthen the company's financial structure. The buyback offer is set to be published on the company's website and in the Federal Gazette by March 28, 2024, with an acceptance period ending on April 16, 2024. The proposed repurchase price for the bond is expected to be 91.07% of the nominal amount, as per the announcement made on March 26, 2024.